Form 4 Filing: Fairmount Healthcare Fund II L.P. Acquires (Grant) shares of $SYRE

STOCK AWARD / GRANT

⚡ MATERIALITY: 1/10

corporate issuer

Spyre Therapeutics, Inc.

Ticker: $SYRE

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-05-27

Shares: 8,026

Market Price Activity

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Fairmount Healthcare Fund II L.P., holds the title of Director at Spyre Therapeutics, Inc..

On 2026-05-27, the insider transacted 8,026 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

Fairmount Healthcare Fund II L.P. (Director) was granted $0 of $SYRE

Post-Transaction Position: 8,026 shares

SEC Accession No: 0001636282-26-000069 (CIK: 1769651)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

Yahoo Finance$SYRE Quote & Profile

OpenCorporates RegistryVerify Corporate Identity

Google News$SYRE News Coverage